Ofatumumab is a monoclonal antibody that affects the actions of the body's immune system. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect healthy cells from damage. Ofatumumab is used to treat chronic lymphocytic leukemia. Ofatumumab is usually given after other medications have been tried without success. Ofatumumab may also be used for purposes not listed in this medication guide.
Arzerra is a monoclonal antibody that affects the body’s immune system. In a nut shell, Arzerra is a cancer treating medicinal syrup that contains the active substance ofatumumab. The purpose of such monoclonal drugs is to single out and destroy certain given cells in the body. Such actions provide protection to healthy cells from destruction.